The price-to-earnings ratio for Medtronic Plc (NYSE: MDT) is above average at 30.06x, Company’s 36-month beta value is 0.85.Analysts have differing opinions on the stock, with 7 analysts rating it as a “buy,” 4 as “overweight,” 12 as “hold,” and 0 as “sell.”
The public float for MDT is 1.28B, and currently, short sellers hold a 0.83% ratio of that floaft. The average trading volume of MDT on October 14, 2024 was 6.30M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
MDT) stock’s latest price update
Medtronic Plc (NYSE: MDT) has seen a rise in its stock price by 0.57 in relation to its previous close of 88.85. However, the company has experienced a 1.25% gain in its stock price over the last five trading sessions. zacks.com reported 2024-10-11 that In the latest trading session, Medtronic (MDT) closed at $89.36, marking a +0.57% move from the previous day.
MDT’s Market Performance
MDT’s stock has risen by 1.25% in the past week, with a monthly drop of -0.71% and a quarterly rise of 15.93%. The volatility ratio for the week is 1.03% while the volatility levels for the last 30 days are 1.20% for Medtronic Plc The simple moving average for the last 20 days is 0.38% for MDT stock, with a simple moving average of 6.39% for the last 200 days.
Analysts’ Opinion of MDT
Many brokerage firms have already submitted their reports for MDT stocks, with RBC Capital Mkts repeating the rating for MDT by listing it as a “Outperform.” The predicted price for MDT in the upcoming period, according to RBC Capital Mkts is $105 based on the research report published on October 10, 2024 of the current year 2024.
Oppenheimer, on the other hand, stated in their research note that they expect to see MDT reach a price target of $94, previously predicting the price at $92. The rating they have provided for MDT stocks is “Perform” according to the report published on August 21st, 2024.
UBS gave a rating of “Neutral” to MDT, setting the target price at $90 in the report published on August 15th of the current year.
MDT Trading at 2.24% from the 50-Day Moving Average
After a stumble in the market that brought MDT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -2.33% of loss for the given period.
Volatility was left at 1.20%, however, over the last 30 days, the volatility rate increased by 1.03%, as shares sank -0.71% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +11.02% upper at present.
During the last 5 trading sessions, MDT rose by +1.25%, which changed the moving average for the period of 200-days by +8.58% in comparison to the 20-day moving average, which settled at $89.02. In addition, Medtronic Plc saw 8.47% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at MDT starting from PARKHILL KAREN L, who proposed sale 2,668 shares at the price of $90.00 back on Aug 26 ’24. After this action, PARKHILL KAREN L now owns shares of Medtronic Plc, valued at $240,120 using the latest closing price.
Martha Geoffrey, the Chairman and CEO of Medtronic Plc, sale 19,113 shares at $83.77 during a trade that took place back on Jun 07 ’24, which means that Martha Geoffrey is holding 143,348 shares at $1,601,001 based on the most recent closing price.
Stock Fundamentals for MDT
Current profitability levels for the company are sitting at:
- 0.18 for the present operating margin
- 0.63 for the gross margin
The net margin for Medtronic Plc stands at 0.12. The total capital return value is set at 0.07. Equity return is now at value 7.92, with 4.35 for asset returns.
Based on Medtronic Plc (MDT), the company’s capital structure generated 0.37 points at debt to capital in total, while cash flow to debt ratio is standing at 0.25. The debt to equity ratio resting at 0.58. The interest coverage ratio of the stock is 7.75.
Currently, EBITDA for the company is 8.38 billion with net debt to EBITDA at 3.34. When we switch over and look at the enterprise to sales, we see a ratio of 4.33. The receivables turnover for the company is 5.42for trailing twelve months and the total asset turnover is 0.36. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.13.
Conclusion
In a nutshell, Medtronic Plc (MDT) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
